Cargando…
An Evaluation of Three Ways of Communicating Carrier Status Results to the Parents of Children in a Neonatal Sickle Cell Screening Programme
Aim: Sickle cell disease (SCD) is the most frequent monogenic disease worldwide; ~5–7% of the world population carry a hemoglobin disorder trait. In the US, one in every 1,941 newborns has SCD, whereas one in every 3,000 newborns in France is affected - resulting in 385 new cases and 5,883 newly ide...
Autores principales: | Rémus, Christelle, Stanislas, Aurélie, Bouazza, Naïm, Gauthereau, Valérie, Polak, Michel, Blanche, Stéphane, Niakaté, Assa, Gluckman, Eliane, Tréluyer, Jean-Marc, Munnich, Arnold, Girot, Robert, Cavazzana, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318296/ https://www.ncbi.nlm.nih.gov/pubmed/32637386 http://dx.doi.org/10.3389/fped.2020.00300 |
Ejemplares similares
-
Transfusion‐related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatory
por: Ribeil, Jean‐Antoine, et al.
Publicado: (2018) -
Family cord blood banking for sickle cell disease: a twenty-year experience in two dedicated public cord blood banks
por: Rafii, Hanadi, et al.
Publicado: (2017) -
Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy
por: Magnani, Alessandra, et al.
Publicado: (2020) -
Bayesian Modeling Immune Reconstitution Apply to CD34+ Selected Stem Cell Transplantation for Severe Combined Immunodeficiency
por: Diana, Jean-Sebastien, et al.
Publicado: (2022) -
S265: MATERNAL AND PERINATAL OUTCOMES OF SICKLE CELL DISEASE IN PREGNANCY: A NATIONWIDE STUDY IN FRANCE.
por: Corsia, Alice, et al.
Publicado: (2023)